Introducing the
Trilogy Enhanced Income Fund
The Trilogy Enhanced Income Fund invests directly and indirectly in a portfolio of cash, fixed interest investments and other financial assets such as a range of short to medium term bank deposits, bills of exchange, promissory notes, bonds, fixed or floating rate debt securities and income securities.
To enhance returns, part of the portfolio is invested in the Trilogy Monthly Income Trust (Trust). The Trust is a pooled mortgage trust that invests in loans secured by registered first mortgages of Australian property.
Platform Availability
Fund Rating
*Click the image to download the report.
2The information contained in the Foresight Analytics report and encapsulated in the investment rating is of a general nature only. The report and rating reflect the opinion of Foresight Analytics and Ratings Pty Limited (AFSL 494552). It does not take into account an individual’s objectives, financial situation, or needs. Professional advice should be sought before making an investment decision. A fee has been paid by the fund manager for the production of the report and investment rating.
3The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
Fund information
The Trilogy Enhanced Income Fund has delivered consistent returns in a low yield environment to its investors since launch in 20174.
4Past performance is not a reliable indicator of future performance.
5Whilst the unit price is fixed, capital losses can occur in circumstances where an asset of the Fund incurs a capital loss.
Historical performance
Data provided in the below table is current as at 31 December 2024.
Historical Performance 6,7 | |||||||
---|---|---|---|---|---|---|---|
1 month | 3 month | 6 month | 1 year | 3 year | 5 year | Inception | |
Return | 0.52% | 1.54% | 3.10% | 6.20% | 4.92% | 4.19% | 4.16% |
Target Return | 0.50% | 1.47% | 2.95% | 5.85% | 4.68% | 3.49% | 3.27% |
Excess Return | 0.02% | 0.07% | 0.15% | 0.35% | 0.24% | 0.70% | 0.89% |
6 All distribution rates quoted are variable, net of fees, costs and taxes and assume no distribution reinvestment. Past performance is not a reliable indicator of future performance.
7 3-year, 5-year and inception data are reported on a per annum basis. The target benchmark is the Official Cash Rate target plus 1.50% p.a assuming reinvestment of distribution but before fees and expenses and taxes, over a rolling 12 months period.
Risks
You should be aware that investing in the Trilogy Enhanced Income Fund involves risks that could lead to the loss of part or all of your capital or diminished returns. For example, there are investment and structural risks associated with the underlying investments and separate risks associated with the underlying asset classes of cash and cash-style investments and indirect investment in a portfolio of loans secured by registered first mortgages over Australian real estate. You should read the PDS in full.
Important documents
Trust updates
Date | Document | Type |
---|---|---|
11.10.2024 | Annual Report 2024 | Investor update |
10.04.2024 | New Product Disclosure Statement (PDS)- April 2024 | Investor update |
10.04.2024 | New Target Market Determination (TMD)- April 2024 | Investor update |
30.06.2023 | Annual Report 2023 | Investor update |
30.09.2022 | Target Market Determination (TMD) – September 2022 | Investor update |
30.06.2022 | Annual Report 2022 | Investor update |
01.10.2021 | Target Market Determination (TMD) – October 2021 | Investor update |
30.06.2021 | Annual Report 2021 | Investor update |
28.07.2020 | Product Disclosure Statement (PDS) – July 2020 | Investor update |
30.06.2020 | Annual Report 2020 | Investor update |